NewEdge Advisors’s Biohaven BHVN Stock Holding History

NewEdge Advisors’s Portfolio BHVN Stock Details BHVN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$8.67K	Hold	1,025	–	–	﹤0.01%	3439
2025 Q4	$11.6K	Buy	1,025 +25	+3%	+$310	﹤0.01%	3426
2025 Q3	$15K	Buy	+1,000	New	+$14.6K	﹤0.01%	3215
2024 Q2	–	Sell	-55	Closed	-$3.01K	–	3809
2024 Q1	$3.01K	Sell	55 -27	-33%	-$1.34K	﹤0.01%	3289
2023 Q4	$3.51K	Hold	82	–	–	﹤0.01%	3219
2023 Q3	$2.13K	Sell	82 -2	-2%	-$42	﹤0.01%	3029
2023 Q2	$2.01K	Sell	84 -72	-46%	-$1.24K	﹤0.01%	3094
2023 Q1	$2.13K	Sell	156 -4,964	-97%	-$79K	﹤0.01%	3018
2022 Q4	$21.8K	Buy	+5,120	New	+$72.3K	﹤0.01%	2095

Other funds holding BHVN

Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

SCM

Suvretta Capital Management New York $3.92B AUM 86.67% 1-Year Est. Return

Stifel Financial St. Louis, Missouri $109B AUM 21.36% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

IAM

Infinitum Asset Management Fort Lauderdale, Florida $801M AUM 8.83% 1-Year Est. Return

TCM

TCG Crossover Management Palo Alto, California $3.5B AUM 1,165.83% 1-Year Est. Return

RPSM

Royalty Pharma Sub-Manager New York $173M AUM

D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

NewEdge Advisors's BHVN Position: Q1 2026 in Review

NewEdge Advisors held its Biohaven (BHVN) position steady in Q1 2026 at 1,025 shares worth $8.67K. The position accounts for ﹤0.01% of the portfolio, ranked #3439.

NewEdge Advisors first reported a position in BHVN in Q4 2022 and has held it in 9 quarters since. The position peaked at $21.8K in Q4 2022. 275 funds tracked by Wall St. Rank hold BHVN as of Q1 2026.

NewEdge Advisors held 1,025 shares of Biohaven worth $8.67K as of Q1 2026.
NewEdge Advisors left its Biohaven share count unchanged in Q1 2026.
Biohaven made up ﹤0.01% of NewEdge Advisors's portfolio in Q1 2026, its #3439 holding.
NewEdge Advisors first reported a position in Biohaven in Q4 2022 and has held it in 9 quarters since.
NewEdge Advisors's Biohaven position peaked at $21.8K in Q4 2022.
275 funds tracked by Wall St. Rank held Biohaven as of Q1 2026.

Based on NewEdge Advisors's 13F filing for Q1 2026, filed 18 May 2026.